Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA1c according to American Diabetes Association criteria

Diabetes Care

Volumn 37, Issue 5, 2014, Pages 1447-1453

  Di Pino, Antonino ^a   Scicali, Roberto ^a   Calanna, Salvatore ^a   Urbano, Francesca ^a   Mantegna, Concetta ^a   Rabuazzo, Agata Maria ^a   Purrello, Francesco ^a   Piro, Salvatore ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GLUCOSE; HEMOGLOBIN A1C; SOLUBLE ADVANCED GLYCATION END PRODUCT RECEPTOR; UNCLASSIFIED DRUG; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; IMMUNOGLOBULIN RECEPTOR;

ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; AUGMENTATION INDEX; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; REPRODUCIBILITY; RISK ASSESSMENT; ADOLESCENT; ANALYSIS; BLOOD; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; ECHOGRAPHY; FEMALE; GLUCOSE TOLERANCE TEST; MALE; MIDDLE AGED; PREDIABETIC STATE; RISK FACTOR; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; RECEPTORS, IMMUNOLOGIC; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84899104171     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-2357     Document Type: Article

References (32)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-S69
2. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999;22:233-240 (Pubitemid 29056916)
3. Gillett MJ. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 2009; 32: 1327-1334.
4. Clin Biochem Rev 2009;30: 197-200
5. Sattar N. Revisiting the links between glycaemia, diabetes and cardiovascular disease. Diabetologia 2013;56:686-695
6. Won KB, Chang HJ, Park SH, Hong SY, Jang Y, Chung N. High serum advanced glycation end-products predict coronary artery disease irrespective of arterial stiffness in diabetic patients. Korean Circ J 2012;42:335-340
7. Sakurai S, Yonekura H, Yamamoto Y, et al. The AGE-RAGE system and diabetic nephropathy. J Am Soc Nephrol 2003;14 (Suppl. 3):S259 -S263
8. Koyama H, Shoji T, Yokoyama H, et al. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2005;25:2587-2593 (Pubitemid 43732283)
9. Nin JW, Jorsal A, Ferreira I, et al. Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes 2010;59:2027-2032
10. Spadaro L, Alagona C, Palermo F, et al. Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction. Nutr Metab Cardiovasc Dis 2011;21:206-212
11. Mosca A, Goodall I, Hoshino T, et al.; International Federation of Clinical Chemistry and Laboratory Medicine, IFCC Scientific Division. Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group. Clin Chem Lab Med 2007;45:1077 -1080
12. Di Pino A, Alagona C, Piro S, et al. Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. Atherosclerosis 2012;223:458-462
13. Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 2009; 32:281 -286
14. Orencia AJ, Daviglus ML, Dyer AR, Walsh M, Greenland P, Stamler J. One-hour postload plasma glucose and risks of fatal coronary heart disease and stroke among nondiabetic men and women: the Chicago Heart Association Detection Project in Industry (CHA) Study. J Clin Epidemiol 1997; 50:1369-1376 (Pubitemid 28034990)
15. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241 (Pubitemid 34163575)
16. Nürnberger J, Keflioglu-Scheiber A, Opazo Saez AM, Wenzel RR, Philipp T, Schäfers RF. Augmentation index is associated with cardiovascular risk. J Hypertens 2002;20: 2407-2414 (Pubitemid 36026853)
17. Weber T, Auer J, O'Rourke MF, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109:184-189 (Pubitemid 38114137)
18. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr; Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14-22 (Pubitemid 29024679)
19. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229- 234
20. Brun E, Nelson RG, Bennett PH, et al.; Verona Diabetes Study. Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care 2000;23:1119-1123 (Pubitemid 30616799)
21. Succurro E, Marini MA, Arturi F, et al. Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 2009;207: 245-249
22. Sciacqua A, Miceli S, Carullo G, et al. One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care 2011;34:1406-1411
23. Bobbert T, Mai K, Fischer-Rosinsky A, Pfeiffer AF, Spranger J. A1C is associated with intima-media thickness in individuals with normal glucose tolerance. Diabetes Care 2010;33:203 -204
24. Katakami N, Matsuhisa M, Kaneto H, et al. Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients. Diab Vasc Dis Res 2008;5:190-197
25. Basta G, Sironi AM, Lazzerini G, et al. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. J Clin Endocrinol Metab 2006;91:4628-4634 (Pubitemid 44833448)
26. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis 2008;196:9-21
27. Silbernagel G, Grammer TB, Winkelmann BR, Boehm BO, März W. Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography. Diabetes Care 2011;34:1355 -1361
28. Liang J, Zhou N, Teng F, et al. Hemoglobin A1c levels and aortic arterial stiffness: the Cardiometabolic Risk in Chinese (CRC) study. PLoS ONE 2012;7:e38485
29. Zhang M, Bai Y, Ye P, et al. Type 2 diabetes is associated with increased pulse wave velocity measured at different sites of the arterial systembut not augmentation index in a Chinese population. Clin Cardiol 2011; 34:622 -627
30. Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension 2001;37:1429-1433 (Pubitemid 34225387)
31. Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 2009;54:1328-1336
32. Henry RM, Kostense PJ, Spijkerman AM, et al.; Hoorn Study. Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 2003;107:2089 -2095